SANOFICONR
Invest Now

Sanofi Consumer Healthcare India Share Price
₹4,935.10 -3.1 (-0.06%)
21 Apr, 2025 13:41
Start SIP in
SANOFICONR
Performance
- Low
- ₹4,931
- High
- ₹4,950
- 52 Week Low
- ₹4,212
- 52 Week High
- ₹5,375
- Open Price₹4,931
- Previous Close₹4,938
- Volume10,409
Investment Returns
- Over 1 Month + 3.32%
- Over 3 Month + 2.11%
- Over 6 Month + 2.31%
- Over 1 Year + 30.81%
Smart Investing Starts Here Start SIP with Sanofi Consumer Healthcare India for Steady Growth!
Sanofi Consumer Healthcare India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 62.8
- PEG Ratio
- 6.4
- Market Cap Cr
- 11,366
- P/B Ratio
- 49.5
- Average True Range
- 94.71
- EPS
- 87.44
- Dividend Yield
- 1.1
- MACD Signal
- 32.15
- RSI
- 61.5
- MFI
- 81.99
Sanofi Consumer Healthcare India Financials
Sanofi Consumer Healthcare India Technicals
EMA & SMA
Current Price
₹4,935.10
-3.1
(-0.06%)

-
- Bearish Moving Average 1
-
- Bullish Moving Average 12
- 20 Day
- ₹4,848.86
- 50 Day
- ₹4,807.06
- 100 Day
- ₹4,821.65
- 200 Day
- -
Resistance and Support
4931.07
- R3 5,001.83
- R2 4,975.87
- R1 4,957.03
- S1 4,912.23
- S2 4,886.27
- S3 4,867.43
Sanofi Consumer Healthcare India Corporate Actions - Bonus, Splits, Dividends
Sanofi Consumer Healthcare India F&O
About Sanofi Consumer Healthcare India
- NSE Symbol
- SANOFICONR
- BSE Symbol
- 544250
- Managing Director
- Mr. Himanshu Bakshi
- ISIN
- INE0UOS01011
Similar Stocks to Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India FAQs
Sanofi Consumer Healthcare India share price is ₹4,935 As on 21 April, 2025 | 13:27
The Market Cap of Sanofi Consumer Healthcare India is ₹11365.8 Cr As on 21 April, 2025 | 13:27
The P/E ratio of Sanofi Consumer Healthcare India is 62.8 As on 21 April, 2025 | 13:27
The PB ratio of Sanofi Consumer Healthcare India is 49.5 As on 21 April, 2025 | 13:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.